Image Guided Therapy Devices Market Size, Trends, Share, Growth, and Opportunity Forecast, 2025 – 2032 Global Industry Analysis By Type (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, Fluoroscopy, Endoscopes, Others), By Application (Cardiology, Oncology, Neurology, Gastroenterology, Orthopedics, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Academic & Research Institutes), and By Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

Region: Global
Published: June 2025
Report Code: CGNHLS1473
Pages: 242

Global Image Guided Therapy Devices Market Report Overview

The Global Image Guided Therapy Devices Market was valued at USD 513.0 Million in 2024 and is anticipated to reach a value of USD 769.6 Million by 2032 expanding at a CAGR of 5.2% between 2025 and 2032.

Image Guided Therapy Devices Market

To Learn More About This Report, Request A Free Sample Copy

The United States dominates the Image Guided Therapy Devices market, accounting for roughly 35% of global revenue. With a mature healthcare infrastructure and high procedural volumes in neurovascular and cardiovascular interventions, U.S. providers have rapidly adopted advanced image-guided platforms such as CBCT and multisystem fluoroscopy. This dominance is reinforced by robust reimbursement mechanisms and a high number of minimally invasive procedures performed annually.

Image Guided Therapy Devices are witnessing rapid evolution driven by integrated imaging modalities and procedural guidance. Advances include enhanced C-arm mobility, real-time 3D visualization, and seamless integration of real-time imaging with treatment systems for neurovascular and oncologic procedures. Manufacturers continue to develop lighter, motorized, and AI-enabled C-arms to streamline workflows and support same-day discharge. High-volume cardiac and interventional oncology centers increasingly demand systems that provide enhanced procedural accuracy, lower radiation exposure, and better patient throughput.

How is AI Transforming Image Guided Therapy Devices Market?

Artificial intelligence is revolutionizing image-guided therapy by enhancing image clarity, automating workflow processes, and enabling predictive device maintenance. For example, GE HealthCare introduced CleaRecon DL in 2024: a deep-learning reconstruction tool for cone-beam CT that filters out streak artifacts and improves clinician confidence in complex interventional cases such as neuro, liver, and vascular procedures. Clinical users report that CleaRecon DL enables more consistent CBCT use by removing image noise, directly enhancing diagnostic accuracy in interventional suites.

In parallel, NVIDIA collaborated with GE HealthCare in 2025 to develop “autonomous imaging” platforms, leveraging simulation environments to train X-ray and ultrasound systems. These simulated workflows—covering patient setup, scan planning, and image quality checks—are being tested virtually before deployment. This shift toward “physical AI” allows imaging systems to autonomously manage routine tasks, reducing technologist burden and extending access to underserved regions.

AI is also being embedded into C-arm control and image guidance systems. Philips’ Azurion neuro biplane now includes auto-rotation and beam angulation adjustments to aid rapid stroke interventions without manual repositioning. Meanwhile, predictive analytics platforms use AI to forecast system failures by analyzing component health and usage patterns, minimizing unplanned downtime during interventional procedures.

Together, these developments show that AI is transforming image-guided therapy by improving image quality, workflow efficiency, and uptime reliability. AI’s role is shifting from diagnostic support to active control systems in image-guided platforms—a trend gathering pace across cardiology, oncology, and neurovascular fields.

In 2024, INOVAIT and the Government of Canada invested USD 10.7 million to support seven commercialization-focused R&D projects integrating AI into IGT (Image-Guided Therapy) technologies—part of a total CAD 32 million infusion into the Canadian sector—to accelerate machine learning tools across therapy platforms and promote high precision IGT innovation.”

Dynamics of the Image Guided Therapy Devices Market

DRIVER:

Increasing Demand for Real-Time, High-Precision Procedural Imaging

Clinicians increasingly demand instant 2D/3D guidance during minimally invasive interventions. This demand is fueling development and adoption of devices like neuro biplane systems, which offer instant auto-switching between imaging modes and real-time beam angulation to support stroke, neurovascular, and cardiac procedures. US interventional cardiology labs now perform over 1 million angioplasty and intracoronary device cases annually; AI-integrated platforms reduce scan-to-treatment time by an average of 15%, directly boosting procedural throughput and patient outcomes.

RESTRAINTS:

Limited Access to Skilled Staff for Complex IGT Systems

Implementation of AI-driven image guidance requires highly trained personnel for system operation and interpretation. Smaller and rural centers often lack access to such expertise, leading to underutilization. For example, while urban hospitals may operate 5–8 interventional sessions weekly using advanced platforms, rural centers conduct fewer than 2. This discrepancy limits market expansion in non-urban areas despite availability of mobile, motorized C-arm units.

OPPORTUNITY:

Expansion of AI-Enabled Remote and Hybrid Interventional Suites

Image-guided therapy systems are integrating cloud-based AI tools, enabling specialists to remotely guide and supervise procedures. Cloud adoption allows off-site radiologists to collaborate via generative AI that improves report quality and reduces editing time. This paves the way for remote stroke and oncology interventions in under-resourced regions, expanding both access and utilization.

CHALLENGE:

High Capital Costs and Infrastructure Demands for Advanced IGT Systems

Purchasing image-guided platforms (C-arm with AI reconstruction) can exceed USD 2 million per unit. Hospitals must also invest in infrastructure like radiation shielding, sterile interventional suites, and AI-ready networks. This capital intensity poses a major barrier for small and mid-size hospitals, especially in developing regions. Even with medical equipment loans and leasing options, the initial cost often delays budget cycles and procurement decisions by 12–18 months.

Image Guided Therapy Devices Market Trends

  • Modular, Motorized C-arm Adoption: Image-guided therapy is shifting toward modular and motorized C-arm devices. These systems support pre-procedural 3D planning and real-time guidance in neurovascular and cardiac interventions. The motorized, table-side controllable units reduce procedure times and minimize staff fatigue during extended cases. This is particularly evident in North America and Europe, where high-volume interventional oncology and stroke programs demand precise, user-friendly imaging solutions.

  • Hybrid Suite Integration: Hospitals are increasingly converting standard ORs into hybrid suites equipped with image-guided platforms capable of supporting both surgical and interventional procedures. This allows surgeons and interventionalists to collaborate within the same space. Large academic centers are adopting these integrated workflows to treat oncology and vascular cases using multi-modality imaging systems.

  • Cloud-First AI-Enabled Workflow Platforms: AI and cloud integration are transforming image-guided environments into more connected, efficient care delivery hubs. Cloud-based platforms integrate generative AI to streamline workflow, reduce reporting time, and enhance diagnostic accuracy. These systems are enabling collaborative decision-making and optimized procedural planning across hospital networks.

  • Focus on Radiation Dose Optimization: Due to rising concerns about radiation exposure, manufacturers are embedding AI into dose reduction technology. AI-based reconstruction engines are now available and effectively reduce artifacts while maintaining image clarity, enabling clinicians to perform safer interventions while preserving diagnostic confidence.

Segmentation Analysis

The Image Guided Therapy Devices Market is segmented based on type, application, and end-user, offering a comprehensive view of the market’s evolving dynamics. Each segment plays a vital role in shaping demand patterns and driving innovation. The market’s diversity ensures wide applicability across multiple healthcare domains — from hospitals to specialty clinics and research institutions. Recent technological advancements in imaging, robotics, and artificial intelligence are further accelerating the adoption of image-guided therapy across new treatment areas. Insights into segmentation trends highlight both the maturity of established categories and the fast-emerging opportunities in minimally invasive and personalized interventions.

By Type

The Image Guided Therapy Devices Market by type includes computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, fluoroscopy, endoscopes, and others. Among these, CT-based image guidance systems hold the largest market share owing to their widespread use in interventional oncology, cardiovascular, and trauma applications. CT provides high-resolution, cross-sectional imaging that enhances procedural precision. However, the MRI-guided therapy segment is the fastest growing. MRI’s ability to offer superior soft-tissue contrast without ionizing radiation makes it ideal for applications in neurosurgery, liver ablation, and prostate interventions. Innovations such as MR-LINACs (MRI-guided linear accelerators) are transforming radiotherapy procedures.  Ultrasound-guided systems also demonstrate solid growth potential, driven by their portability and real-time feedback, especially in peripheral vascular and musculoskeletal procedures. As image guidance becomes more integrated and AI-driven, hybrid systems combining multiple modalities are gaining traction, offering clinicians greater flexibility and procedural control.

By Application

The Image Guided Therapy Devices Market by application is segmented into cardiology, oncology, neurology, gastroenterology, orthopedics, and others. Oncology applications dominate the market as image-guided therapies play a central role in tumor localization, biopsy guidance, ablation procedures, and radiation therapy planning. Increasing global cancer incidence and demand for minimally invasive treatments drive this segment’s growth. Neurology is the fastest growing application area. The rising prevalence of stroke and neurovascular disorders, combined with the need for precision in complex brain and spine interventions, fuels demand for advanced neuro image-guided systems. Recent advances in intraoperative imaging and AI-based navigation tools are accelerating adoption in neurosurgical centers. Cardiology remains a strong segment as well, supported by innovations in structural heart interventions such as TAVR (transcatheter aortic valve replacement) and complex coronary procedures. The ability to perform real-time, image-guided cardiac interventions with lower radiation and contrast exposure is driving this segment’s relevance.

By End-User Insights

The Image Guided Therapy Devices Market by end-user is segmented into hospitals, ambulatory surgical centers (ASCs), specialty clinics, and academic & research institutes. Hospitals are the leading end-users, accounting for the largest share of the market. The availability of advanced imaging infrastructure, multidisciplinary expertise, and growing demand for complex interventions ensures strong hospital adoption. Ambulatory surgical centers (ASCs) represent the fastest growing segment. ASCs benefit from lower overheads and increasing patient preference for outpatient procedures, especially in orthopedics, cardiology, and oncology. The shift toward minimally invasive procedures aligns perfectly with ASC capabilities, driving investments in mobile and modular image-guided systems. Specialty clinics, such as cancer centers and neurology clinics, are increasingly adopting tailored image-guided platforms to deliver high-precision, outpatient-based therapies. Meanwhile, academic & research institutes continue to contribute by validating AI-powered innovations and supporting the next wave of hybrid and intelligent image-guided therapy systems.

Region-Wise Market Insights

North America accounted for the largest market share at 39.8% in 2024; however, Asia-Pacific is expected to register the fastest growth, expanding at a CAGR of 6.4% between 2025 and 2032.

Image Guided Therapy Devices Market by Region

To Learn More About This Report, Request A Free Sample Copy

The North American dominance is driven by high healthcare spending, advanced hospital infrastructure, and early adoption of image-guided technologies. On the other hand, rapid urbanization, an aging population, and a rising focus on minimally invasive procedures are fueling demand in Asia-Pacific. Emerging economies are actively investing in diagnostic and surgical imaging equipment, while the presence of regional manufacturers is bringing down device costs, encouraging wider accessibility and market expansion.

North America Image Guided Therapy Devices Market Trends

Technological Maturity and High Adoption of Hybrid Systems Driving Growth

The North American market benefits from mature healthcare systems, making it the largest global market for image-guided therapy devices. In 2024, the region's revenue stood at approximately USD 204.2 million. The United States continues to dominate due to its large base of tertiary hospitals and cancer care centers. Procedures such as MRI-guided focused ultrasound and CT-guided ablations are becoming standard practice. Canada also shows steady growth driven by expanding diagnostic imaging coverage and AI-based procedural innovations. The region is seeing an uptick in hybrid operating rooms equipped with robotic surgical systems and integrated imaging platforms, increasing procedural precision and reducing recovery time.

Europe Image Guided Therapy Devices Market Trends

Rising Geriatric Population and Public-Private Collaborations Boost Market Penetration

Europe remains a strong market, holding approximately 28.7% share in 2024, supported by a growing geriatric population and increasing burden of cancer and cardiovascular diseases. Germany leads the regional market followed by France and the UK, where image-guided technologies are being incorporated into surgical procedures across government and private institutions. EU-wide initiatives to improve access to minimally invasive therapy, particularly in oncology and neurology, are contributing to stable growth. The adoption of MRI and PET-based guided therapies is expanding due to improvements in imaging resolution and real-time data integration.

Asia-Pacific Image Guided Therapy Devices Market Trends

Growing Investments and Urban Healthcare Expansion Fuel Rapid Growth

Asia-Pacific is the most dynamic region, with market revenue reaching USD 96.7 million in 2024. China and India are key contributors, driven by government investments in diagnostic infrastructure and growing awareness of early disease detection. Japan remains a pioneer in robotic-assisted surgeries and image-guided radiation therapy. The demand for mobile and compact imaging systems is increasing in tier 2 and 3 cities, addressing accessibility gaps in rural healthcare. Additionally, the rise of local manufacturers and lower device costs are enabling smaller hospitals to adopt image-guided therapies, fueling strong regional growth.

South America Image Guided Therapy Devices Market Trends

Expanding Oncology Services and Tele-Imaging Boost Regional Demand

South America’s market is growing steadily, with Brazil accounting for over 55% of the region’s market share in 2024. Public health initiatives and foreign investments are expanding oncology and neurology services that rely heavily on image guidance. Argentina and Colombia are also witnessing increased demand due to the development of private diagnostic chains and tele-imaging networks. Portable ultrasound and fluoroscopy devices are particularly popular in remote areas. The region is expected to see further demand for affordable and minimally invasive therapies driven by increasing cancer and cardiovascular disease rates.

Middle East & Africa Image Guided Therapy Devices Market Trends

Infrastructure Modernization and Specialty Clinics Lead Market Momentum

The Middle East & Africa market, though smaller in value, is witnessing notable advancements. In 2024, the market generated an estimated USD 30.8 million, with Saudi Arabia and the UAE leading adoption. Rising investments in specialty hospitals and cancer care centers are driving the demand for CT and MRI-guided therapies. Africa’s market is still in early growth stages, but portable and battery-operated imaging devices are gaining traction in rural clinics. Cross-border partnerships and skill development initiatives are helping clinicians adopt image-guided surgical protocols for improved patient outcomes.

Top Two Countries by Market Share in 2024

  • United States – USD 178.9 million, tops due to high procedural volume and advanced imaging infrastructure

  • Germany – USD 61.2 million, driven by strong insurance coverage and hospital adoption of hybrid ORs

Market Competition Landscape

The Image Guided Therapy Devices market is characterized by intense competition among global players investing heavily in R&D, partnerships, and regional expansion. Companies are introducing motorized mobile C-arms, fusion imaging platforms, and AI-integrated guidance systems to gain a technological edge. For example, the launch of high-power table-side controllable C-arm systems has prompted rivals to accelerate innovation in automated workflows and dose optimization features. Market players are also focusing on strategic collaborations—such as alliances with tech firms to integrate virtual reality planning tools and cloud-based AI analytics—strengthening their clinical and commercial portfolios. Competitive differentiation hinges on offering comprehensive solutions that combine hardware, software, and post-sales support. To capture emerging markets, leading firms are expanding distribution networks across Asia, Latin America, and the Middle East, offering scalable, cost-effective device configurations tailored to local infrastructure. Mergers and acquisitions continue to reshape the landscape, enabling consolidation of imaging modalities, imaging-prescription software, and tele-guided services under unified platforms. Despite this intense competition, customer loyalty is being reinforced through long-term service contracts, training programs, and integrated data-driven outcome tracking across installed systems.

Companies Profiled in the Image Guided Therapy Devices Market Report

  • Philips Healthcare

  • GE HealthCare

  • Siemens Healthineers

  • Canon Medical Systems

  • Fujifilm Holdings

  • Hologic

  • Bracco Imaging

  • Elekta

Technology Insights for the Image Guided Therapy Devices Market

The technology landscape is shifting toward smarter, integrated imaging and therapy platforms. Motorized C-arms with table-side control, like the Zenition 90, enable clinicians to perform complex vascular and orthopedic procedures with greater autonomy, enhancing throughput and staff ergonomics. Fusion imaging systems—combining real-time ultrasound, CT, and fluoroscopy—are becoming ubiquitous in structural heart and tumor ablation centers, as they enable precise needle targeting and contrast-free procedures. AI-driven reconstruction engines, such as deep-learning tools, now automatically reduce noise and artifacts in cone-beam CT, improving image quality for neuro and liver interventions. Light-guided navigation technologies (e.g., fiber-optic-based LumiGuide) are reducing radiation exposure in endovascular procedures. Cloud-connected imaging suites are also emerging, enabling remote specialists to assist in procedure planning and navigation, boosting access in under-resourced regions. Portable and battery-operated ultrasound and C-arm devices share advanced software platforms compatible with centralized PACS and reporting systems. Integration with robotic arms for biopsy and ablation is also advancing, with sub-millimeter tracking accuracy and closed‑loop force feedback enabling safer interventional workflows. These technology ecosystems—merging hardware, software, AI, and connectivity—are redefining standards of safety, efficiency, and precision in therapy delivery.

Recent Developments in the Global Image Guided Therapy Devices Market

  • In February 2024, Philips introduced LumiGuide, a light-guided navigation system using fiber-optic real-shape technology. It’s been used in over 900 aortic repair procedures across the U.S. and Europe, reducing procedural time by 37% and radiation exposure by 56%.

  • In June 2024, Canada's INOVAIT and the federal government jointly invested USD 10.7 million across seven image-guided therapy R&D projects integrating AI and machine learning, leveraging an additional USD 21.3 million in private funding.

  • In June 2024, Philips’ motorized mobile C-arm system, Zenition 90, received FDA 510(k) clearance. Following independent usability testing, 100% of clinicians said table-side control offers full C-arm movement autonomy, while 97% acknowledged time-saving workflow features.

  • In June 2024, ClearPoint Neuro launched the SmartFrame OR and ClearPoint Prism laser therapy systems and OR platform tailored for epilepsy and movement disorder surgeries, focusing on neurosurgical precision and minimally invasive outcomes.

Scope of Image Guided Therapy Devices Market Report

This report encompasses a wide-ranging analysis of image-guided therapy devices, including all major hardware types (CT, MRI, fluoroscopy, ultrasound, mobile C-arms, light-guided systems, robotic arms), leading applications (cardiology, oncology, neurology, orthopedics, gastroenterology), and end-user categories (hospitals, ASCs, specialty clinics, research institutes). It covers global and regional markets—North America, Europe, Asia-Pacific, South America, and Middle East & Africa—offering a detailed examination of competitive landscapes, market dynamics, technological insights, and recent innovations. Strategic insights are provided across R&D initiatives, regulatory and clinical approval timelines, as well as adoption barriers such as infrastructure prerequisites, personnel training, and reimbursement systems. The report also highlights emerging opportunities in AI integration, tele-guidance, hybrid OR expansions, and localized manufacturing. It delivers actionable guidance for device developers, healthcare providers, investors, and policy makers seeking to optimize deployment strategies, scale commercial operations, and improve clinical efficacy in the evolving image-guided therapy ecosystem.

Image Guided Therapy Devices Market Report Summary

Report Attribute / Metric Report Details
Market Name Global Image Guided Therapy Devices Market
Market Revenue (2024) USD 513.0 Million
Market Revenue (2032) USD 769.6 Million
CAGR (2025–2032) 5.2%
Base Year 2024
Forecast Period 2025–2032
Historic Period 2020–2024
Segments Covered

By Type

  • Computed Tomography (CT)

  • Magnetic Resonance Imaging (MRI)

  • Ultrasound

  • Fluoroscopy

  • Endoscopes

  • Others

By Application

  • Cardiology

  • Oncology

  • Neurology

  • Gastroenterology

  • Orthopedics

  • Others

By End-User

  • Hospitals

  • Ambulatory Surgical Centers

  • Specialty Clinics

  • Academic & Research Institutes

Key Report Deliverables Revenue Forecast, Growth Trends, Market Dynamics, Segmental Overview, Regional and Country-wise Analysis, Competition Landscape, Technological Insights, Recent Developments
Regions Covered North America, Europe, Asia-Pacific, South America, Middle East & Africa
Key Players Analyzed Philips Healthcare, GE HealthCare, Siemens Healthineers, Canon Medical Systems, Fujifilm Holdings, Hologic, Bracco Imaging, Elekta
Customization & Pricing Available on Request (10% Customization is Free)

Frequently Asked Questions

logo
Navigating Trends, Illuminating Insights
Have any custom research requirements?
Congruence Market Insights is a leading market research company dedicated to providing unparalleled insights and strategic intelligence. Our expert analysts deliver actionable data, empowering businesses to make informed decisions in a dynamic marketplace. Trust us to navigate your path to success.
© 2025 Congruence Market Insights
Place An Order
Privacy
Terms and Conditions